Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocugen Inc
(NQ:
OCGN
)
1.270
-0.020 (-1.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Why Ocugen Shares Are Trading Higher
April 08, 2024
Ocugen shares are trading higher by 7.7% during Monday's session. The company announced U.S. FDA clearance of the IND amendment to initiate a Phase 3 clinical trial of OCU400.
Via
Benzinga
Exposures
Product Safety
Why Is Ocugen (OCGN) Stock Up 7% Today?
April 08, 2024
Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results.
Via
InvestorPlace
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 08, 2024
Via
Benzinga
Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication
April 08, 2024
From
Ocugen
Via
GlobeNewswire
OCGN Stock Alert: Why Is Ocugen Up 20% Today?
April 05, 2024
With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications.
Via
InvestorPlace
Why Ocugen Shares Are Popping Off
April 03, 2024
Ocugen shares are trading higher by 14% during Wednesday's session. The company provided an update on its business activities and financial status for 2023.
Via
Benzinga
What's Going On With Ocugen Stock?
March 26, 2024
Ocugen shares are trading lower by 6.3% during Tuesday's session. The stock is pulling back after hitting a new 52-week high Monday and following recent, key business updates.
Via
Benzinga
Why Ocugen Stock Is Climbing Today
April 05, 2024
Ocugen shares are trading higher Friday after the company announced it has received approval to proceed dosing with the medium dose of OCU410 in the dose-escalation phase of its Phase 1/2 study. Ocugen...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410—a Modifier Gene Therapy—in Phase 1/2 ArMaDa Study for Geographic Atrophy
April 05, 2024
From
Ocugen
Via
GlobeNewswire
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
OCUGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the Firm
April 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Ocugen (OCGN) Q4 2023 Earnings Call Transcript
April 02, 2024
OCGN earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
OCGN Stock Falls Ocugen Must Restate Its Financials
April 02, 2024
After an impressive rally to date, investors appear to be in selling mode with OCGN stock on the news it will need to restate its financials.
Via
InvestorPlace
Ocugen Provides Business Update with Certain Financials for the Year Ending 2023
April 02, 2024
Conference Call and Webcast Today at 8:30 a.m. ET
From
Ocugen
Via
GlobeNewswire
Earnings Scheduled For April 2, 2024
April 02, 2024
Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.
Via
Benzinga
Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410ST—a Modifier Gene Therapy—in GARDian Study for Stargardt Disease
April 01, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen to Host Conference Call on Tuesday, April 2 at 8:30 A.M. ET to Provide Business Update with Certain Financials for the Year Ending 2023
April 01, 2024
From
Ocugen
Via
GlobeNewswire
Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 01, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via
Benzinga
Is the Stock Market Closed on Good Friday 2024?
March 25, 2024
Investors are wondering if the stock market is closed on Good Friday 2024 as they prepare for the upcoming Easter weekend.
Via
InvestorPlace
Why Is Landos Biopharma (LABP) Stock Up 168% Today?
March 25, 2024
Landos Biopharma stock is up on Monday as LABP investors learn about a massive acquisition deal with AbbVie that values it at $137.5 million.
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Up 20% Today?
March 25, 2024
Ocugen stock is heading higher on Friday as investors in OCGN shares react to a dismissed class action lawsuit against the company.
Via
InvestorPlace
Topics
Lawsuit
Exposures
Financial
Legal
What's Going On With Ocugen (OCGN) Shares?
March 25, 2024
Ocugen shares are trading higher by 25.6% during Monday's session. The stock is trading higher, potentially on upward momentum, following a number of key announcements last week.
Via
Benzinga
3 Stocks Under $5 Ready to Outpace the Market
March 25, 2024
Discover three stocks under $5 from SaaS transformation to biotech advancements, that showcase immense potential for market outperformance.
Via
InvestorPlace
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 22, 2024
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.
Via
Benzinga
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday
March 22, 2024
U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
March 22, 2024
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion
Via
Benzinga
Guess? Posts Upbeat Earnings, Joins Lufax, Nortech Systems And Other Big Stocks Moving Higher On Thursday
March 21, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 250 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 21, 2024
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.